These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8732493)

  • 21. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.
    Levin K; Daa Schroeder H; Alford FP; Beck-Nielsen H
    Diabetologia; 2001 Jul; 44(7):824-33. PubMed ID: 11508266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperinsulinaemia is associated with stimulation of cholesterol synthesis in both type 1 and type 2 diabetes.
    Stinson JC; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1993 Jun; 10(5):412-9. PubMed ID: 8334819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
    Wolffenbuttel BH; Weber RF; Weeks L; van Koetsveld PM; Verschoor L
    Diabetes Res; 1990 Feb; 13(2):79-84. PubMed ID: 2091874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High plasma free fatty acids decrease splanchnic glucose uptake in patients with non-insulin-dependent diabetes mellitus.
    Tomita T; Yamasaki Y; Kubota M; Tohdo R; Katsura M; Ikeda M; Nakahara I; Shiba Y; Matsuhisa M; Hori M
    Endocr J; 1998 Apr; 45(2):165-73. PubMed ID: 9700469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Groop L; Ekstrand A; Forsblom C; Widén E; Groop PH; Teppo AM; Eriksson J
    Diabetologia; 1993 Jul; 36(7):642-7. PubMed ID: 8359582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.
    Eriksson KF; Lindgärde F
    Diabetologia; 1996 May; 39(5):573-9. PubMed ID: 8739917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.
    Marena S; Tagliaferro V; Montegrosso G; Pagano A; Scaglione L; Pagano G
    Diabete Metab; 1994; 20(1):15-9. PubMed ID: 8056129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man.
    Yki-Järvinen H; Taskinen MR; Koivisto VA; Nikkilä EA
    Diabetologia; 1984 Sep; 27(3):364-9. PubMed ID: 6389242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of glucose and lipid abnormalities in black NIDDM subjects.
    Chaiken RL; Banerji MA; Pasmantier R; Huey H; Hirsch S; Lebovitz HE
    Diabetes Care; 1991 Nov; 14(11):1036-42. PubMed ID: 1797484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benfluorex decreases insulin resistance and improves lipid profiles in obese type 2 diabetic patients.
    Bianchi R; Bongers V; Bravenboer B; Erkelens DW
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():29S-34S. PubMed ID: 8299486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.
    Forsblom CM; Eriksson JG; Ekstrand AV; Teppo AM; Taskinen MR; Groop LC
    Diabetologia; 1995 Mar; 38(3):363-9. PubMed ID: 7758885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.
    Paolisso G; Tataranni PA; Foley JE; Bogardus C; Howard BV; Ravussin E
    Diabetologia; 1995 Oct; 38(10):1213-7. PubMed ID: 8690174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.
    Sørensen LP; Andersen IR; Søndergaard E; Gormsen LC; Schmitz O; Christiansen JS; Nielsen S
    Diabetes; 2011 Jan; 60(1):88-96. PubMed ID: 20858686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia.
    Curtin A; Deegan P; Owens D; Collins P; Johnson A; Tomkin GH
    Acta Diabetol; 1995 Dec; 32(4):244-50. PubMed ID: 8750763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
    Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.
    Widén E; Ekstrand A; Saloranta C; Franssila-Kallunki A; Eriksson J; Schalin-Jäntti C; Groop L
    Diabetologia; 1992 Dec; 35(12):1140-5. PubMed ID: 1478365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
    Vestergaard H; Parving HH; Hansen L; Pedersen O
    Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension.
    Ligtenberg JJ; Van Tol A; Van Haeften TW; Sluiter WJ; Reitsma WD; Dullaart RP
    J Intern Med; 1996 Oct; 240(4):233-42. PubMed ID: 8918515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.